Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela Alexe

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Cancer Cell|June 15, 2021
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcomaBiniam Adane, Gabriela Alexe, Bo Kyung A Seong, et al.
Science Translational Medicine|March 9, 2018
Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemiaFlorence F Wagner, Lina Benajiba, Arthur J Campbell, et al.
Cancer Discovery|October 5, 2017
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic LeukemiaRiadh Lobbardi, Jordan Pinder, Barbara Martinez-Pastor, et al.
Cancer Cell|June 18, 2013
In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signalingPeter G Miller, Fatima Al-Shahrour, Kimberly A Hartwell, et al.
Cancer Discovery|August 23, 2020
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Frank Ling, Camille Vaganay, et al.
Leukemia|April 27, 2022
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemiaBryann Pardieu, Justine Pasanisi, Frank Ling, et al.
Nature Genetics|April 22, 2014
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylationAndrew A Lane, Bjoern Chapuy, Charles Y Lin, et al.
Cancer Discovery|September 5, 2014
The genomic landscape of pediatric Ewing sarcomaBrian D Crompton, Chip Stewart, Amaro Taylor-Weiner, et al.
The Journal of Clinical Investigation|December 5, 2017
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2Liying Chen, Gabriela Alexe, Neekesh V Dharia, et al.
Science Translational Medicine|April 1, 2021
Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitorBlandine Roux, Camille Vaganay, Jesse D Vargas, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cancer Cell|June 15, 2021
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcomaBiniam Adane, Gabriela Alexe, Bo Kyung A Seong, et al.
Science Translational Medicine|March 9, 2018
Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemiaFlorence F Wagner, Lina Benajiba, Arthur J Campbell, et al.
Cancer Discovery|October 5, 2017
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic LeukemiaRiadh Lobbardi, Jordan Pinder, Barbara Martinez-Pastor, et al.
Cancer Cell|June 18, 2013
In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signalingPeter G Miller, Fatima Al-Shahrour, Kimberly A Hartwell, et al.
Cancer Discovery|August 23, 2020
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Frank Ling, Camille Vaganay, et al.
Leukemia|April 27, 2022
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemiaBryann Pardieu, Justine Pasanisi, Frank Ling, et al.
Nature Genetics|April 22, 2014
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylationAndrew A Lane, Bjoern Chapuy, Charles Y Lin, et al.
Cancer Discovery|September 5, 2014
The genomic landscape of pediatric Ewing sarcomaBrian D Crompton, Chip Stewart, Amaro Taylor-Weiner, et al.
The Journal of Clinical Investigation|December 5, 2017
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2Liying Chen, Gabriela Alexe, Neekesh V Dharia, et al.
Science Translational Medicine|April 1, 2021
Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitorBlandine Roux, Camille Vaganay, Jesse D Vargas, et al.
Pageof 9